Research overviews, clinical data summaries, and sourcing guides for UK researchers. Based on published Phase 2/3 trial data.
A complete research overview of Retatrutide (LY3437943) — mechanism of action, TRIUMPH Phase 2 efficacy data, and how it differs from Tirzepatide and Semaglutide.
A research overview of Retatrutide side effects from TRIUMPH Phase 2 data. GI tolerability, dose-dependence, timeline, and comparison with Tirzepatide and Semaglutide.
Research dosage guide for Retatrutide based on TRIUMPH Phase 2 titration schedules. Dose escalation from 2mg to 12mg weekly, pen format guidance, and storage.
Direct comparison of Retatrutide, Tirzepatide (Mounjaro) and Semaglutide (Ozempic/Wegovy) — mechanisms, Phase 2/3 weight loss data, and side effect profiles.
Guide to sourcing Retatrutide in the UK for research. What to verify — COA, HPLC purity, cold chain delivery, and UK pricing from £125.